Global pediatric vaccine market to hit $23B by 2015-

Subscribe Search This Thread

Start a New Thread

post #1 of 7

12/14/12 at 4:30am

Thread Starter

1,108 Posts. Joined 7/2007
Select All Posts By This User

Global pediatric vaccine market to hit $23B by 2015

The global pediatric vaccine market will likely hit a value of more than $23 billion by 2015, a market analysis shows.

Quote:

GlaxoSmithKline ($GSK) leads the charge with nearly a quarter of the global market.

From 2005 to 2011, pediatric vaccines doubled their market share, according to a Renub Research analysis, and will continue to shoot upward. Analysts can attribute much of that growth to blockbuster vaccines such as Pfizer's ($PFE) Prevnar 7 and Prevnar 13, Glaxo's Rotarix and Merck's ($MRK) Rotateq. Pediatric proprietary vaccines will probably lead the vaccine market with just less than 60% market share by 2015, the report says.

I know a popular sentiment is that vaccines are not that lucrative for Pharma compared to other drugs. That may be if you do side by side comparison, however 23 billion isn't chump change and the trend is such that the market continues to grow. If vaccines and pediatric vaccines in particular were not money makers for these companies they wouldn't make them.

post #4 of 7

1/4/13 at 1:13pm

1,172 Posts. Joined 1/2012
Select All Posts By This User

In fact many pharmaceutical companies are pulling out of making vaccines (I think Rrrrrachel has posted that I information here several times) and there are growing concerns that there could be supply problems in the future.

post #5 of 7

1/4/13 at 3:09pm

3,136 Posts. Joined 1/2012
Select All Posts By This User

In recent years a few vaccines have become more profitable. So what about the last several decades? Or the motivation for vaccines like mmr which are not proprietary and don't make big money?

post #6 of 7

1/4/13 at 4:36pm

1,694 Posts. Joined 1/2012
Select All Posts By This User

Quote:

Originally Posted by Rrrrrachel

In recent years a few vaccines have become more profitable. So what about the last several decades? Or the motivation for vaccines like mmr which are not proprietary and don't make big money?

Why don't you tell us about the motivations for Merck's lying about the efficacy of the mumps portion of the MMR, and their extensive efforts to cover that up?

post #7 of 7

1/4/13 at 5:06pm